Identification of the LH surge by measuring intact and total immunoreactivity in urine for prediction of ovulation time.

Fertility Gonadotropin Infertility Luteinizing hormone Menstruation Ovulation Ovulation predictor kit Urinary

Journal

Hormones (Athens, Greece)
ISSN: 2520-8721
Titre abrégé: Hormones (Athens)
Pays: Switzerland
ID NLM: 101142469

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 25 05 2021
accepted: 07 04 2022
pubmed: 26 5 2022
medline: 14 9 2022
entrez: 25 5 2022
Statut: ppublish

Résumé

In our earlier study, we separated three different molecular forms of urinary LH-ir (U-LH-ir) by gel filtration and identified them by immunoassay in urine from regularly menstruating women on periovulatory days. U-LH-ir is composed of intact luteinizing hormone (LH), its free beta-subunit (LHβ), and the core fragment of LHβ (LHβcf), the latter two establishing the non-intact portion of LH-ir. The aim was to determine whether timing of ovulation can be improved by detecting different molecular forms of U-LH-ir in women of reproductive age. We determined intact and total U-LH-ir in 14 regularly menstruating women on consecutive periovulatory days during the menstrual cycle. Non-intact LH-ir was calculated as the arithmetic difference between total and intact LH-ir. In addition, LH-ir was determined in both serum and urine from four of the women throughout the menstrual cycle. During the LH surge, U-LH-ir consisted mainly of intact LH and presented with an abrupt increase. Intact U-LH-ir dropped rapidly within 1 day after the surge, reaching baseline levels at the end of the luteal phase. In contrast, LHβcf in urine increased further 1 day after the surge. After this, most of the U-LH-ir consisted of LHβcf and it remained strongly elevated (over fivefold compared to intact LH) for the first 3 days after the LH surge, moderately elevated (over threefold) thereafter until day + 5, and mildly elevated until day + 7. Total and non-intact LH-ir are potential add-on characteristics which can be utilized in ovulation predictor kits to measure LH-ir in urine beyond the LH surge during a broader time frame, thereby paving the way for more precise prediction of the timing of ovulation than that obtained with currently available products.

Identifiants

pubmed: 35614178
doi: 10.1007/s42000-022-00368-9
pii: 10.1007/s42000-022-00368-9
pmc: PMC9464748
doi:

Substances chimiques

Progesterone 4G7DS2Q64Y
Estradiol 4TI98Z838E
Luteinizing Hormone 9002-67-9

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

413-420

Subventions

Organisme : Suomen Lääketieteen Säätiö
ID : 3583

Informations de copyright

© 2022. The Author(s).

Références

J Steroid Biochem. 1982 Dec;17(6):695-702
pubmed: 7176659
Anim Reprod Sci. 2011 Apr;124(3-4):229-36
pubmed: 20869180
Minerva Endocrinol (Torino). 2022 Feb 15;:
pubmed: 35166468
Obstet Gynecol. 1996 Jan;87(1):13-7
pubmed: 8532248
Fertil Steril. 2011 Jun;95(7):2184-9
pubmed: 20688324
Hum Reprod. 1999 Jul;14(7):1835-9
pubmed: 10402400
Stat Med. 1991 Feb;10(2):221-40
pubmed: 2052801
Biometrics. 1982 Jun;38(2):397-406
pubmed: 7115870
Hum Reprod. 2007 Mar;22(3):635-43
pubmed: 17204526
BMJ Glob Health. 2019 Apr 25;4(2):e001403
pubmed: 31139458
J Clin Endocrinol Metab. 1989 Sep;69(3):510-7
pubmed: 2474563
Hum Reprod. 1998 Apr;13(4):826-35
pubmed: 9619532
J Clin Endocrinol Metab. 1983 Oct;57(4):792-6
pubmed: 6411753
Steroids. 2013 Oct;78(10):1035-40
pubmed: 23831784
Hum Reprod. 2013 Jan;28(1):138-51
pubmed: 23081872
Fertil Steril. 2007 Sep;88(3):684-90
pubmed: 17434509
J Steroid Biochem. 1982 Feb;16(2):345-7
pubmed: 7078170
Popul Stud (Camb). 1980 Jul;34(2):397-400
pubmed: 22077133
N Engl J Med. 1995 Dec 7;333(23):1517-21
pubmed: 7477165
Fertil Steril. 1983 May;39(5):647-55
pubmed: 6840308
Fertil Steril. 1998 Jul;70(1):56-9
pubmed: 9660421
J Clin Endocrinol Metab. 1987 Apr;64(4):730-6
pubmed: 3546353
Clin Chem. 1991 Oct;37(10 Pt 1):1745-8
pubmed: 1914178
Front Neuroendocrinol. 1998 Jul;19(3):151-86
pubmed: 9665835
Mol Cell Endocrinol. 1979 Feb;13(2):181-90
pubmed: 446881
Best Pract Res Clin Endocrinol Metab. 2013 Dec;27(6):783-93
pubmed: 24275190
Adv Contracept. 1997 Jun-Sep;13(2-3):83-95
pubmed: 9288325
J Clin Endocrinol Metab. 1992 Jan;74(1):164-71
pubmed: 1727817
J Steroid Biochem. 1989 Oct;33(4B):733-7
pubmed: 2689781
Am J Obstet Gynecol. 1980 Oct 15;138(4):383-90
pubmed: 6775535
Eur J Obstet Gynecol Reprod Biol. 2000 Jul;91(1):59-64
pubmed: 10817880
J Clin Endocrinol Metab. 1990 Feb;70(2):371-8
pubmed: 1688864
Pediatr Res. 1994 Aug;36(2):221-6
pubmed: 7970938
Endocrine. 1995 Dec;3(12):881-7
pubmed: 21153216
J Endocrinol. 1992 Jun;133(3):459-66
pubmed: 1377221
Int J Fertil. 1967 Jan-Mar;12(1 Pt 2):77-126
pubmed: 5419031
BMJ. 2000 Nov 18;321(7271):1259-62
pubmed: 11082086
Clin Chem. 1991 Mar;37(3):333-40
pubmed: 2004439
Endocrinology. 1993 Sep;133(3):985-9
pubmed: 7689962

Auteurs

And Demir (A)

Pediatric Research Center, New Children's Hospital, University of Helsinki and Helsinki University Hospital, Biomedicum II, 6th floor, Tukholmankatu 8 A, FIN-00290, Helsinki, Finland. drand@demir.net.

Matti Hero (M)

Pediatric Research Center, New Children's Hospital, University of Helsinki and Helsinki University Hospital, Biomedicum II, 6th floor, Tukholmankatu 8 A, FIN-00290, Helsinki, Finland.

Henrik Alfthan (H)

HUSLAB, Helsinki University Hospital, Helsinki, Finland.

Amro Passioni (A)

Department of Clinical Chemistry, Helsinki University Hospital, Helsinki, Finland.

Juha S Tapanainen (JS)

Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Department of Obstetrics and Gynecology, Medical Research Center, PEDEGO Research Unit, University of Oulu and Oulu University Hospital, Oulu, Finland.

Ulf-Håkan Stenman (UH)

Department of Clinical Chemistry, Helsinki University Hospital, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH